Clinical benefits of hepatocellular carcinoma surveillance: A single-center, hospital-based study

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 999-1003

  Taura, Naota ^a   Hamasaki, Keisuke ^a   Nakao, Kazuhiko ^a   Ichikawa, Tatsuki ^a   Nishimura, Daisuke ^a   Goto, Takashi ^a   Fukuta, Mariko ^a   Kawashimo, Hiroshi ^a   Motoyoshi, Yasuhide ^a   Shibata, Hidetaka ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Imaging techniques; Screening; fetoprotein

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HOSPITAL; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HOSPITALS; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644824977     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.999     Document Type: Article

References (23)

1. McGlynn KA, Tsao L, Hsing AW, Devesa SS and Fraumeni JF Jr: International trends and patterns of primary liver cancer. Int J Cancer 94: 290-296, 2001. (Pubitemid 32911426)
2. El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36: S74-S83, 2002.
3. El-Serag HB: Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35: S72-S78, 2002.
4. Kiyosawa K and Tanaka E: Characteristics of hepatocellular carcinoma in Japan. Oncology 62: 5-7, 2002. (Pubitemid 34702013)
5. Omata M, Tateishi R, Yoshida H and Shiina S: Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 127: S159-S166, 2004. (Pubitemid 39423384)
6. Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R and Rodes J: Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. Hepatology 12: 753-760, 1990. (Pubitemid 20349262)
7. Schafer DF and Sorrell MF: Hepatocellular carcinoma. Lancet 353: 1253-1257, 1999. (Pubitemid 29168472)
8. Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Rinse B and Meyers WC: Hepatocellular carcinoma. Br J Surg 85: 1319-1331, 1998. (Pubitemid 28468331)
9. Ngan H, Lai CL, Fan ST, Lai EC, Yuen WK and Tso WK: Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: four year follow-up. J Vasc Interv Radiol 7: 419-425, 1996. (Pubitemid 126729062)
10. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y and Kobayashi K: Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 12: 680-687, 1990. (Pubitemid 20349251)
11. Lai CL, Lau JY, Wu PC, Hui WM, Lai EC, Fan ST, Ngan H and Lin HJ: Subclinical hepatocellular carcinoma in Hong Kong Chinese. Oncology 49: 347-353, 1992.
12. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, de Fazio C, Tommasini M, Donato MF, Piva A, di Carlo V and Dioguardi N: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325: 675-680, 1991.
13. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, Reboullet P and Beaugrand M: Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 20: 65-71, 1994. (Pubitemid 24043087)
14. Hamasaki K, Nakata K, Tsutsumi T, Tsuruta S, Nakao K, Kato Y, Shima M, Koji T and Nagataki S: Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan. J Med Virol 40: 146-149, 1993. (Pubitemid 23169743)
15. Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, Tajima H, Tanioka H, Yano M and Nagataki S: Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 74: 2234-2238, 1994. (Pubitemid 24322276)
16. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M, et al: Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 22: 1027-1033, 1995.
17. Dohmen K, Shirahama M, Onohara S, Miyamoto Y, Torii Y, Irie K and Ishibashi H: Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: an analysis of 547 patients. Hepatol Res 18: 110-121, 2000. (Pubitemid 30458681)
18. Marrero JA and Lok AS: Newer markers for hepatocellular carcinoma. Gastroenterology 127: S113-S119, 2004. (Pubitemid 39423378)
19. Daniele B, Bencivenga A, Megna AS and Tinessa V: Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127: S108-S112, 2004. (Pubitemid 39423377)
20. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A and Torzilli G: No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol 22: 522-526, 1995.
21. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG and Lai CL: Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 31: 330-335, 2000. (Pubitemid 30078596)
22. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM and Lok AS: NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36: 1349-1354, 2002.
23. Yuen MF and Lai CL: Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness. Ann Oncol 14: 1463-1467, 2003.